‘This Is Astounding’: Overnight, Millions More Americans Could Be Labeled Obese

7 in 10 U.S. Adults Could Fall Under New Obesity Definition

BOSTON — A major shift in how doctors define obesity could fundamentally reshape medical practice, according to groundbreaking research analyzing health data from over 300,000 Americans.

Scientists found that adopting a new obesity framework endorsed by 76 professional medical organizations increased obesity rates from 42.9% to 68.6% among study participants. This dramatic jump stems from including people who have dangerous belly fat despite maintaining what doctors previously considered a healthy weight.

Published in JAMA Network Open, the study analyzed data from the All of Us research program and represents the first large-scale examination of how new obesity guidelines would affect healthcare. The research tracked participants for four years to document real health outcomes, not just theoretical classifications.

Beyond the Scale: Why Waist Size Matters

Rather than relying solely on the height-to-weight calculation that has dominated medicine for decades, the new approach incorporates waist circumference, waist-to-hip ratio, and waist-to-height ratio alongside BMI to create a more complete health assessment.

Under the new framework, someone can be classified as having obesity through three different pathways:

The waist measurements use specific cutoffs that vary by sex and race. For example, elevated waist circumference is generally defined as 40 inches or more for men and 35 inches or more for women, though these thresholds are adjusted for different ethnic groups who may face health risks at lower measurements.

The research team, led by Dr. Lindsay Fourman from Massachusetts General Hospital, found that traditional BMI measurements miss many people with dangerous fat distribution patterns. The research team found that belly fat, regardless of overall weight, serves as a key predictor of metabolic disease..

Scientists identified a category called “anthropometric-only obesity” affecting 78,047 study participants. These individuals maintain normal BMI scores while carrying elevated measurements around their midsection. Among this group, 17,426 people (22.3%) had BMI scores doctors previously labeled as normal or underweight.

Health Risks That BMI Misses

Researchers tracked participants to document who developed serious health problems. People with this hidden form of obesity faced significantly higher risks than those without obesity, despite looking healthy on standard scales.

Compared to people without obesity, those with the waist-centered type were 76% more likely to have organ problems. They also faced more than double the risk of developing diabetes and 55% higher risk of heart disease.

The research team found that people with this form of obesity often developed high blood pressure, physical limitations, and sleep apnea. These conditions typically emerge gradually, making early identification through waist measurements potentially valuable for prevention.

Age and Demographics Drive Changes

The study revealed striking patterns across different groups. Among participants aged 18 to 29, obesity prevalence under the new definition reached 43.9%. The most dramatic change occurred among seniors: 78.3% of Americans over 70 in the study met criteria for obesity under the new framework, compared to previous BMI-based classifications.

This age-related increase reflects how body composition changes over time, with fat increasingly accumulating around the midsection as people get older. Among people over 70 in the study, 54.4% had what researchers called “clinical obesity” indicating the presence of organ dysfunction or physical limitations.

The research also found notable differences by race and gender. Asian participants saw the largest relative increase in obesity rates, jumping 90.3% from 2,439 participants (27.0%) to 4,641 participants (51.4%) under the new definition. Male participants were more likely than female participants to have anthropometric-only obesity, affecting 32.5% of men versus 21.7% of women in the study.

Obesity Treatment Guidelines Face Major Overhaul

The new framework could dramatically alter who receives obesity medications and treatments. Currently, about 45% of study participants would qualify for weight-loss drugs based on today’s guidelines. Under the new approach, roughly half of those people would be moved to a lower priority for treatment since they’d be classified as having earlier-stage obesity.

Additionally, among participants with the most serious form of obesity under the new definition, about 1 in 4 wouldn’t qualify for current weight-loss medications. This mismatch shows that treatment guidelines may need a major overhaul.

The new guidelines recommend different treatment approaches. People with clinical obesity would get the most aggressive treatment, including medications and surgery when appropriate. Those with the earlier stage might receive lifestyle counseling first, with medications reserved for specific cases.

Clinical vs. Preclinical Obesity

The new approach introduces two categories based on whether health problems are already present. “Clinical obesity” means someone has existing health problems or physical limitations that may be related to their weight pattern. “Preclinical obesity” means concerning measurements are present but serious health issues haven’t developed yet.

To determine clinical obesity, doctors look for specific conditions including high blood pressure, diabetes, sleep apnea, joint problems, liver issues, or physical limitations like difficulty with daily activities. The presence of any of these alongside elevated body measurements would classify someone as having clinical obesity.

About 36% of all study participants had clinical obesity, with rates climbing sharply with age. The distinction matters because people with clinical obesity faced the highest risks of future diabetes, heart disease, and death.

Even the earlier stage carried meaningful health risks. People with preclinical obesity had more than three times the risk of developing diabetes and 40% higher risk of heart problems compared to those without obesity.

The study tracked the most common health problems associated with clinical obesity: high blood pressure topped the list, followed by physical limitations and sleep apnea. The research revealed that organ dysfunction itself, even without obesity, significantly increased health risks.

For healthcare systems and insurance companies, these changes could carry massive financial consequences. Medicare and other payers may need to reassess coverage policies as the eligible population for obesity treatments potentially shifts substantially.

The study’s authors acknowledge that implementing the new definition would require more work and resources than current BMI-based screening. However, they argue that the improved ability to identify health risks may justify the additional effort, particularly if integrated into electronic health record systems.

The research’s obesity prevalence using traditional BMI-based criteria (42.9%) closely aligns with Centers for Disease Control and Prevention estimates for the US population (40.3%), supporting the potential broader applicability of these findings to American adults generally.

Disclaimer: This article summarizes recent peer-reviewed research for general information only. It is not a substitute for medical advice. Readers should consult qualified healthcare professionals for individualized assessment or treatment.